Movement Disorders. Eric Kraus, MD! Neurology!

Similar documents
Parkinson s Disease. Sirilak yimcharoen

Movement Disorders: A Brief Overview

Professor Tim Anderson

Professor Tim Anderson

Treatment of Parkinson s Disease and of Spasticity. Satpal Singh Pharmacology and Toxicology 3223 JSMBS

Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O.

Moving fast or moving slow: an overview of Movement Disorders

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease

Optimizing Clinical Communication in Parkinson s Disease:

Drug Therapy of Parkinsonism. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology

The symptoms of the Parkinson s disease may vary from person to person. The symptoms might include the following:

Parkinson s Disease Update. Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s

Evaluation and Management of Parkinson s Disease in the Older Patient

Tremor, Rigidity, Tics and Dystonia: The 4 Most Common Movement Disorders

Disorders of Movement M A R T I N H A R L E Y N E U R O L O G Y

STEADY YOUR APPROACH TO TREMOR (OVERVIEW OF DIFFERENTIAL DIAGNOSIS)

MOVEMENT DISORDERS UPDATE H. MURRAY TODD, M.D., F.A.A.N.

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Hyperkinetic movement disorders are. Hyperkinetic Movement Disorders. Cases in Movement Disorders. James case. About Tom

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE

Parkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder

Margo J Nell Dept Pharmacology

Restless Legs Syndrome: Is This a Pain Issue?

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Dr Barry Snow. Neurologist Auckland District Health Board

Involuntary Movements in Children and Adolescents: Is it Seizure, Tic or Something Else?

Parkinson s disease Therapeutic strategies. Surat Tanprawate, MD Division of Neurology University of Chiang Mai

III./3.1. Movement disorders with akinetic rigid symptoms

Parkinson s Disease Current Treatment Options

parts of the gastrointenstinal tract. At the end of April 2008, it was temporarily withdrawn from the US Market because of problems related to

Prior Authorization with Quantity Limit Program Summary

ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE

PARKINSON S PRIMER. Dr. Kathryn Giles MD, MSc, FRCPC Cambridge, Ontario, Canada

10th Medicine Review Course st July Prakash Kumar

Parkinson s Disease Medications: Professionals Edition

8/28/2017. Behind the Scenes of Parkinson s Disease

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

Movement Disorders Will Garrett, M.D Assistant Professor of Neurology

475 GERIATRIC PSYCHOPHARMACOLOGY (p.1)

Cardinal Features of Parkinson s. Management of Parkinson s Disease. Drug Induced Parkinson s. Other Parkinson s Symptoms.

Faculty. Joseph Friedman, MD

Parkinson s Disease: initial diagnosis, initial treatment & non-motor features. J. Timothy Greenamyre, MD, PhD

XADAGO (safinamide) oral tablet

Key Concepts and Issues in Parkinson s Disease in 2016

History Parkinson`s disease. Parkinson's disease was first formally described in 1817 by a London physician named James Parkinson

Treatment of Parkinson s Disease: Present and Future

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

Neurodegenerative Disease. April 12, Cunningham. Department of Neurosciences

Martin A. Samuels, M.D. MOVEMENT DISORDERS

Tremor 101. Objectives 9/30/2015. Importance of tremors

Presented by Joanna O Leary, MD Providence St. Vincent Medical Center Movement Disorder Department

Best Medical Treatments for Parkinson s disease

Objectives. Emerging Treatments in Parkinson s s Disease. Pathology. As Parkinson s progresses it eventually affects large portions of the brain.

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types

Differential Diagnosis of Hypokinetic Movement Disorders

Drug Management of Parkinsonism. By Prof. Mohammad Saleh M. Hassan PhD. (Pharma); MSc. (Ped.); MHPE (Ed.)

Multiple choice questions: ANSWERS

An approach to movement disorders. Kailash Bhatia, DM, FRCP Professor of Clinical Neurology Institute of Neurology Queen Square, London

Restless Legs Syndrome. Brian Koo, M.D. University Hospitals

Clinical Features and Treatment of Parkinson s Disease

Semivoluntary movement (=unvoluntary)

Understanding Parkinson s Disease Important information for you and your loved ones

Parkinson s Disease Initial Clinical and Diagnostic Evaluation. J. Timothy Greenamyre, MD, PhD

M. Carranza M. R. Snyder J. Davenport Shaw T. A. Zesiewicz. Parkinson s Disease. A Guide to Medical Treatment

Movement disorders. Dr Rick Leventer Royal Children s Hospital

Depression & Anxiety. What can I do? What are other possible treatments? What is this? Why does this happen? KEY POINTS

Presented by Meagan Koepnick, Josh McDonald, Abby Narayan, Jared Szabo Mentored by Dr. Doorn

ASSFN Clinical Case: Bilateral STN DBS Implant for Parkinson s Disease

Medication Management & Strategies When the levodopa honeymoon is over

Issues for Patient Discussion

Parkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle

Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Evaluation of Parkinson s Patients and Primary Care Providers

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN

Movement Disorders- Parkinson s Disease. Fahed Saada, MD March 8 th, th Family Medicine Refresher Course St.

Parkinson s Disease Update

2/20/18. History of Parkinson s. What is happening in the brain? DOPAMINE! Epidemiology. Parkinson s Disease. It s much more than tremor

Neurodegenerative diseases

Update on Parkinson s disease and other Movement Disorders October 2018

An Approach to Patients with Movement Disorders

Medications used to treat Parkinson s disease

Understanding Tremor Diagnosis, Cause, Treatment. Monique Giroux, MD Englewood and Fort Collins, CO

Alison Charleston 1 st September 2016

Enhanced Primary Care Pathway: Parkinson s Disease

Table of Contents. Preface... xi. Part I: Introduction to Movement Disorders

Drugs used in Parkinsonism

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Parkinson s Disease. Gillian Sare

Dystonia. The condition can vary from very mild to severe. Dystonia may get worse over time or it may stay the same or get better.

Re-Submission. Scottish Medicines Consortium. rasagiline 1mg tablet (Azilect ) (No. 255/06) Lundbeck Ltd / Teva Pharmaceuticals Ltd.

RESTLESS LEGS SYNDROME IN CHILDREN AND ADOLESCENTS

MAXIMIZING FUNCTION IN PARKINSON S DISEASE

Commonly encountered medications and their side effects - what the generalist needs to know

Dystonia: Title. A real pain in the neck. in All the Wrong Places

Communicating About OFF Episodes With Your Doctor

Parkinson s Disease Update. Colleen Peach, RN, MSN, FNP Movement Disorders Clinic Emory University School of Medicine March 7, 2015

Basics of Restless Legs Syndrome (Willis-Ekbom Disease)

Transcription:

Movement Disorders Eric Kraus, MD! Neurology!

Classify Bradykinesia! Tic! Myoclonus! Tremor! Dystonia! Athetosis! Chorea! Ballismus!

Case 1 This 64 year-old female has had progression of a tremor over the last two years. It affects her writing, eating and sewing.!

Tremor: Definition Involuntary! Rhythmic! Sinusoidal movement!

General types Action!» Kinetic!» Postural!» Intention (cerebellar)! Resting!

Essential tremor Most common movement d/o! Postural and kinetic! Slowly progressive! Prevalence increases with age!» Mean age of presentation 35-45!» Adolescence onset!» 0.5-5% population!» F:M 1:1! Genetic - AD!» FH (+) 50-60%! Distribution!» Hands (symmetric)!» (30%) head, voice, jaw, face!» Legs!» Trunk! Worsened by:!» Emotion!» Hunger!» Fatigue!» Temperature!» Drugs/toxins!

Drugs/toxins Steroids! Thyroid hormone! Lithium! Valproic acid! Cyclosporine! Tricyclics! Beta agonists! Theophyline! Neuroleptics! SSRIs! Caffeine! Nicotine! Arsenic! Lead! Cocaine/amphetamines! Alcohol withdrawal! Benzo withdrawal! Other drug withdrawal!

Tremor work-up None if c/w essential tremor! Resting tremor is the first distinction to make! Review medications! Ask about alcohol, illicit drugs! Labs!» M7, LFTs, TSH, B12!» Ceruloplasmin and serum Cu!» Urine tox screen!» Rare: Vit E, heavy metals! MRI! Review psychiatric history!

Case 2 This 58 year-old male has a left hand tremor at rest and some trouble walking. His hand writing has become smaller, and he no longer smiles.!

PD: Clinical Slow progressive course! 4 cardinal features!» Resting tremor!» Bradykinesia!» Rigidity (cogwheel)!» Postural reflex impairment! Other: dementia, depression, autonomic!

PD: Levodopa Sinemet = carbidopa/levodopa! Most potent drug for PD! Preferred treatment age > 75! Side effects!» GI!» Dyskinesias!» Dementia, hallucinations!» Orthostatic hypotension! Start 25/100 QD, increase q 3d up 3 tid as needed!

PD: Dopamine Agonist Act directly on dopamine receptors! Synergy with levodopa! Longer T1/2! Reduced dyskinesias! Same side effects as levodopa! Initial treatment age < 65! 3rd generation options(pramipexole, Ropinirole)!

PD: MAO-B Inhibitors Rasagiline and Selegiline! Reduction of motor fluctuations! May have neuroprotective effects!» Consider in early onset disease!

PD: COMT inhibitors Block COMT metabolism of levodopa! Dopaminergic SEs!» Reduce levodopa by 30%! Entacapone (Comtan)! Combination drug!» Carbidopa/levodopa/entacapone!

Treatment Flow Chart Levodopa Levodopa COMT AADC AADC COMT 3-OMD Dopamine Dopamine 3-OMD MAO-B COMT 3,4-DHPA 3-MT COMT = catechol-o-methyltransferase AADC = amino acid decarboxylase MAO = monoamine oxidase OMD = O-methyldopa DHPA = dihydroxyphenylacetic acid MT = methoxytyramine COMT Homovanillic acid MAO-B

Case 3 This 58 year-old male is having trouble walking in that he can't seem to keep up with his wife. Several falls have occurred. His hand writing has become smaller, and his wife wonders if he hasn't had a stroke because he no longer smiles. No tremor is present. Sinemet does not help.!

Parkinsonism Parkinson s Disease! Neuroleptic side effect! Post-encephalitic! Toxins (Mn, CO, MPTP)! Dementia! Wilson s disease! Basal ganglia calcifications! Parkinson-plus syndromes!» Progressive supranuclear palsy!» Corticobasoganglionic degeneration!» Multisystem atrophy! Autonomic! Cerebellar!» Diffuse Lewy body disease!

Case 4 This 47 year-old woman who has trouble sitting still in the evenings. Her legs ache. Walking will temporarily relieve the problem.!

Restless Leg Syndrome Characterized by an irresistible urge to move the legs, accompanied by uncomfortable sensations that often occur in the evening or when at rest.!» Creeping, crawling, tingling, aching, burning, pulling, itching, cramping, electric current-like!

RLS Prevalence Very common!» Estimated that 2-15% of the population may have RLS symptoms.!» Age of onset varies widely, but onset of symptoms typically presents before age 50. Severity increases with age.!» Greater in women than men!

RLS Etiology Primary: Thought to be a CNS disorder, but exact mechanism unknown.!» Familial cases indicate potential genetic component.! Secondary: Iron deficiency, neurologic lesions, pregnancy, uremia, drug induced, diabetes mellitus, venous insufficiency.!

RLS - Diagnosis Key diagnostic criteria! Supportive Features! Urge to move legs usually with uncomfortable leg sensations.! Sleep disturbances! Temporary relief with movement partial or total relief by walking or stretching.! Onset or worsening with inactivity! Involuntary leg movements during sleep! Family history! Worsening or onset of sx in the evening or at night.! Positive response to dopaminergic tx.!

RLS - Treatment Non-Pharmacologic:!» Stretching/massage!» Long compressive socks in bed!» Hot/Cold compresses!» Hot bath before bed!» Avoid caffeine and alcohol before bed!» Daily exercise!» Mentally alerting activities! Pharmacologic tx:!» Dopamine agonists: pramipexole, ropinerole!» Carbidopa-levodopa!» Clonazepam!» Gabapentin, Carbamazepine.!» Iron: indicated in all pts (if anemic), esp. pregnant women.!» Opioids!

Case 5 This 42 year-old female complains of a progressive inability to keep her arms and legs still. She has had depression for 10 years. Her father had the same movements starting at the age of 63.!

Huntington Disease Genetics!» CAG repeat!» AD!» Chrom 4! Pathology!» Loss of GABA neurons in striatum!» Diffuse atrophy! Clinical!» Chorea!» Dementia!» Psychiatric! Treatment!» Neuroleptics!» Clonazepam!» Tetrabenazine!» Antidepressants!

Case 6 This 35 year-old woman has trouble writing more than one sentence. It started 2 years ago and progressed. No weakness or sensory loss. She can play the piano and eat fine.!

Focal dystonias Writer s cramp! Spasmodic torticollis! Blepharospasm! Spasmodic dysphonia! Treatment!» Physical therapy!» Botox!» Levodopa!» Anticholinergics!» Baclofen!» Surgery!

Case 7 This 19 year-old male complains of excessive blinking and the need to clear his throat. Onset was at the age of 8. In school he was always in trouble for not paying attention and making abnormal sounds.!

Tourette Syndrome Clinical!» Tics: motor and vocal!» Involuntary but suppressible!» Daily > 1 year!» Onset before age 21 (median age = 7)!» Lifelong, decline with age!» OCD!» ADHD! Prevalence 40/100k! Genetics!» 4:1 M:F!» AD with incomplete penetrance!» MZ twins 80%!

Tourette Syndrome Treatment!» Counseling!» Neuroleptics!» Clonidine!» Topiramate!» Leviteracetam!» Clonazepam!» Dopamine agonists!» Clomipramine!» SSRIs!» Nicotine patch/gum!